v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating activities        
Net income $ 3,059 $ 2,142 $ 8,358 $ 6,303
Adjustments to reconcile net income to net cash provided by operating activities        
Depreciation and amortization 3,151 3,187 9,770 9,500
Stock-based compensation expense 170 156 474 500
Deferred income tax expense 817 671 2,279 1,985
Bad debt expense 299 228 836 663
Losses from sales of receivables 23 46 69 135
Loss on remeasurement of disposal group held for sale 0 0 0 9
Changes in operating assets and liabilities        
Accounts receivable (734) (1,046) (2,436) (3,828)
Equipment installment plan receivables (72) 165 360 563
Inventory (448) (309) (57) 182
Operating lease right-of-use assets 877 886 2,605 2,823
Other current and long-term assets (19) (135) (275) 77
Accounts payable and accrued liabilities (165) 208 (1,861) (1,538)
Short- and long-term operating lease liabilities (805) (692) (2,970) (2,884)
Other current and long-term liabilities (125) (260) (657) (909)
Other, net 111 47 249 119
Net cash provided by operating activities 6,139 5,294 16,744 13,700
Investing activities        
Purchases of property and equipment, including capitalized interest of $(9), $(66), $(26) and $(94) (1,961) (2,424) (6,628) (8,214)
Purchases of spectrum licenses and other intangible assets, including deposits (2,419) (119) (2,636) (225)
Proceeds from sales of tower sites 0 2 0 10
Proceeds related to beneficial interests in securitization transactions 984 1,131 2,832 3,785
Acquisition of companies, net of cash acquired 0 0 (390) 0
Other, net 89 17 50 36
Net cash used in investing activities (3,307) (1,393) (6,772) (4,608)
Financing activities        
Proceeds from issuance of long-term debt 2,480 1,983 8,089 8,446
Repayments of financing lease obligations (347) (304) (1,025) (914)
Repayments of long-term debt (223) (4,474) (3,169) (4,828)
Repurchases of common stock (560) (2,681) (6,541) (10,891)
Dividends on common stock (758) 0 (2,286) 0
Tax withholdings on share-based awards (36) (10) (244) (267)
Other, net (49) (24) (117) (113)
Net cash provided by (used in) financing activities 507 (5,510) (5,293) (8,567)
Change in cash and cash equivalents, including restricted cash and cash held for sale 3,339 (1,609) 4,679 525
Cash and cash equivalents, including restricted cash and cash held for sale        
Beginning of period 6,647 6,808 5,307 4,674
End of period $ 9,986 $ 5,199 $ 9,986 $ 5,199